E
CPUH

Ergoteles’s Compute Health Acquisition Corp. CPUH Stock Holding History

Ergoteles’s Portfolio CPUH Stock Details CPUH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-26,200
Closed -$259K – 2064
2022
Q3 		$259K Buy
+26,200
New +$258K 0.01% 1058

Other funds holding CPUH

SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
ETH
Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SRCM
Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return

Ergoteles's CPUH Position: Q4 2022 in Review

Ergoteles sold out of Compute Health Acquisition Corp. (CPUH) in Q4 2022, closing a stake of 26,200 shares — an estimated $259K sold.

Ergoteles first reported a position in CPUH in Q3 2022 and held it in 1 quarter. The position peaked at $259K in Q3 2022. 25 funds tracked by Wall St. Rank hold CPUH as of Q4 2022.

  • Ergoteles reported no remaining Compute Health Acquisition Corp. position as of Q4 2022 after selling out during the quarter.
  • Ergoteles sold 26,200 Compute Health Acquisition Corp. shares in Q4 2022, an estimated $259K.
  • Ergoteles first reported a position in Compute Health Acquisition Corp. in Q3 2022 and held it in 1 quarter.
  • Ergoteles's Compute Health Acquisition Corp. position peaked at $259K in Q3 2022.
  • 25 funds tracked by Wall St. Rank held Compute Health Acquisition Corp. as of Q4 2022.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.